Hubei Biocause Pharmaceutical Co Ltd - Class A
SZSE:000627 (China)
Â
Class A
Â¥
3.05
(-0.65%)
Nov 28
On watch
Business Description
Hubei Biocause Pharmaceutical Co Ltd
NAICS : 325998
SIC : 2899
ISIN : CNE000000F48
Share Class Description:
SZSE:000627: Class ACompare
Compare
Traded in other countries / regions
000627.China IPO Date
1996-11-12Description
Hubei Biocause Pharmaceutical Co Ltd is a China-based company engaged in life insurance, health insurance, accident insurance, and other life insurance businesses, medicine, and chemical businesses. The company generates its revenue in the form of premiums.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.09 | |||||
| Equity-to-Asset | 0.07 | |||||
| Debt-to-Equity | 1.23 | |||||
| Debt-to-EBITDA | 1.04 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 0.32 | |||||
| Beneish M-Score | -2.16 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.2 | |||||
| 3-Year EBITDA Growth Rate | 43.3 | |||||
| 3-Year EPS without NRI Growth Rate | -39 | |||||
| 3-Year FCF Growth Rate | -34.1 | |||||
| 3-Year Book Growth Rate | 0.3 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.81 | |||||
| 9-Day RSI | 42.73 | |||||
| 14-Day RSI | 44.85 | |||||
| 6-1 Month Momentum % | -7.51 | |||||
| 12-1 Month Momentum % | -2.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.08 | |||||
| Quick Ratio | 1.91 | |||||
| Cash Ratio | 1.22 | |||||
| Days Inventory | 368.3 | |||||
| Days Sales Outstanding | 0.48 | |||||
| Days Payable | 10.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.58 | |||||
| 3-Year Dividend Growth Rate | -45 | |||||
| Forward Dividend Yield % | 3.58 | |||||
| 5-Year Yield-on-Cost % | 0.74 | |||||
| Shareholder Yield % | -27.8 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 82.55 | |||||
| Operating Margin % | 46.04 | |||||
| Net Margin % | -0.33 | |||||
| FCF Margin % | 44.62 | |||||
| ROE % | -0.83 | |||||
| ROA % | -0.06 | |||||
| ROIC % | 3.66 | |||||
| ROC (Joel Greenblatt) % | 375.29 | |||||
| ROCE % | 8.96 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 15.25 | |||||
| PS Ratio | 0.26 | |||||
| PB Ratio | 0.73 | |||||
| Price-to-Tangible-Book | 1.06 | |||||
| Price-to-Free-Cash-Flow | 0.55 | |||||
| Price-to-Operating-Cash-Flow | 0.54 | |||||
| EV-to-EBIT | 0.53 | |||||
| EV-to-EBITDA | 0.53 | |||||
| EV-to-Revenue | 0.24 | |||||
| EV-to-FCF | 0.55 | |||||
| Price-to-Projected-FCF | 0.08 | |||||
| Price-to-Median-PS-Value | 0.33 | |||||
| Earnings Yield (Greenblatt) % | 188.68 | |||||
| FCF Yield % | 156.86 | |||||
| Forward Rate of Return (Yacktman) % | 126.88 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hubei Biocause Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 52,974.105 | ||
| EPS (TTM) (Â¥) | -0.031 | ||
| Beta | 1.22 | ||
| Volatility % | 23.98 | ||
| 14-Day RSI | 44.85 | ||
| 14-Day ATR (Â¥) | 0.062875 | ||
| 20-Day SMA (Â¥) | 3.1045 | ||
| 12-1 Month Momentum % | -2.53 | ||
| 52-Week Range (Â¥) | 2.91 - 3.91 | ||
| Shares Outstanding (Mil) | 4,940.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hubei Biocause Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hubei Biocause Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hubei Biocause Pharmaceutical Co Ltd Frequently Asked Questions
What is Hubei Biocause Pharmaceutical Co Ltd(SZSE:000627)'s stock price today?
The current price of SZSE:000627 is ¥3.05. The 52 week high of SZSE:000627 is ¥3.91 and 52 week low is ¥2.91.
When is next earnings date of Hubei Biocause Pharmaceutical Co Ltd(SZSE:000627)?
The next earnings date of Hubei Biocause Pharmaceutical Co Ltd(SZSE:000627) is .
Does Hubei Biocause Pharmaceutical Co Ltd(SZSE:000627) pay dividends? If so, how much?
The Dividend Yield %  of Hubei Biocause Pharmaceutical Co Ltd(SZSE:000627) is 3.58% (As of Today), Highest Dividend Payout Ratio of Hubei Biocause Pharmaceutical Co Ltd(SZSE:000627) was 1.11. The lowest was 0. And the median was 0.11. The  Forward Dividend Yield % of Hubei Biocause Pharmaceutical Co Ltd(SZSE:000627) is 3.58%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers